FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andy Norman

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
T Guerrero Urbano; Vincent S Khoo; John Staffurth; Andy Norman; F Buffa; A Jackson; E Adams; Vibeke Nordmark Hansen; C Clark; Elizabeth A Miles; Helen A McNair; christopher nutting; C Parker; Rosalind Eeles; Robert A Huddart; Alan Horwich; David P Dearnaley
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study.
Sameer Jhavar; Daniel Brewer; Sandra Edwards; Zsofia Kote-Jarai; Gerhardt Attard; Jeremy Clark; Penny Flohr; Timothy Christmas; Alan Thompson; Matthew Parker; Christopher Shepherd; Ulf-Hakan Stenman; Tania Marchbank; Raymond J Playford; Christopher Woodhouse; Christopher Ogden; Cyril Fisher; Gyula Kovacs; Cathy Corbishley; Charles Jameson; Andy Norman; Johann S de Bono; Anders Bjartell; Rosalind Eeles; Colin S Cooper
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
Sameer Jhavar; J Bartlett; Gyula Kovacs; Cathy Corbishley; David P Dearnaley; Rosalind Eeles; Vincent S Khoo; Robert A Huddart; Alan Horwich; A Thompson; Andy Norman; D Brewer; Colin S Cooper; C Parker
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andy Norman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: T Guerrero Urbano; Vincent S Khoo; John Staffurth; Andy Norman; F Buffa; A Jackson; E Adams; Vibeke Nordmark Hansen; C Clark; Elizabeth A Miles; Helen A McNair; christopher nutting; C Parker; Rosalind Eeles; Robert A Huddart; Alan Horwich; David P Dearnaley
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2010;22(3):236-44.
2009: Sameer Jhavar; Daniel Brewer; Sandra Edwards; Zsofia Kote-Jarai; Gerhardt Attard; Jeremy Clark; Penny Flohr; Timothy Christmas; Alan Thompson; Matthew Parker; Christopher Shepherd; Ulf-Hakan Stenman; Tania Marchbank; Raymond J Playford; Christopher Woodhouse; Christopher Ogden; Cyril Fisher; Gyula Kovacs; Cathy Corbishley; Charles Jameson; Andy Norman; Johann S de Bono; Anders Bjartell; Rosalind Eeles; Colin S Cooper
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
BJU international 2009;103(9):1256-69.
2009: Sameer Jhavar; J Bartlett; Gyula Kovacs; Cathy Corbishley; David P Dearnaley; Rosalind Eeles; Vincent S Khoo; Robert A Huddart; Alan Horwich; A Thompson; Andy Norman; D Brewer; Colin S Cooper; C Parker
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.
Prostate cancer and prostatic diseases 2009;12(2):143-7.
2007: Bhawna Sirohi; David Cunningham; Andy Norman; Kim Last; Ian Chau; Alan Horwich; Jacqui Oates; Geoffrey Chong; Andrew Wotherspoon
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).
Hematology (Amsterdam, Netherlands) 2007;12(2):149-53.
2007: Hendrik-Tobias Arkenau; Claire Gordon; David Cunningham; Andy Norman; Andrew Wotherspoon; Ian Chau
Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience.
Leukemia & lymphoma 2007;48(3):547-50.
2007: Hendrik-Tobias Arkenau; Geoffrey Chong; David Cunningham; David Watkins; R Agarwal; Bhawna Sirohi; M Trumper; Andy Norman; Andrew Wotherspoon; Alan Horwich
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):541-5.
2007: Hendrik-Tobias Arkenau; Geoff Chong; David Cunningham; David Watkins; Bhawna Sirohi; Ian Chau; Andrew Wotherspoon; Andy Norman; Alan Horwich; Estella Matutes
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.
Haematologica 2007;92(2):271-2.
2004: Nick R Maisey; Andy Norman; Yvonne Prior; David Cunningham
Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications?
Clinical oncology (Royal College of Radiologists (Great Britain)) 2004;16(1):48-52.
2003: M Kelleher; Niall Tebbutt; D Cunningham; J Andreyev; M Allen; M Hill; Andy Norman
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2003;15(3):92-7.
2003: A E Guppy; Niall Tebbutt; Andy Norman; David Cunningham
The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44(1):123-5.
2002: Justin S Waters; Diana Tait; David Cunningham; AR Padhani; ME Hill; S Falk; Fiona J Lofts; Andy Norman; Jacqui Oates; A Hill
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1763-70.
2002: Niall Tebbutt; Andy Norman; David Cunningham; Tim Iveson; Matt Seymour; Tamas Hickish; P Harper; Nick R Maisey; K Mochlinski; Yvonne Prior; Mark Hill
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1568-75.
2002: Nick R Maisey; Ian Chau; David Cunningham; Andy Norman; Matt Seymour; Tamas Hickish; Tim Iveson; Mary O'Brien; Niall Tebbutt; Angela Harrington; Mark Hill
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(14):3130-6.
2002: Nick R Maisey; Andy Norman; M Watson; M J Allen; ME Hill; David Cunningham
Baseline quality of life predicts survival in patients with advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(10):1351-7.
2002: Paul Ross; Marianne Nicolson; David Cunningham; J Valle; Matt Seymour; P Harper; T Price; H Anderson; Tim Iveson; Tamas Hickish; Fiona J Lofts; Andy Norman
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):1996-2004.
2001: Ian Chau; Andrew Webb; David Cunningham; Mark Hill; Sheela Rao; S Ageli; Andy Norman; K Gill; A Howard; Daniel Catovsky
An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.
British journal of haematology 2001;115(4):786-92.
2001: Ian Chau; Andrew Webb; David Cunningham; Mark Hill; Justin S Waters; Andy Norman; Alison Massey
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
British journal of cancer 2001;85(9):1258-64.
2000: Nick R Maisey; A Webb; Glenn D Flux; AR Padhani; D C Cunningham; Robert J Ott; Andy Norman
FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.
British journal of cancer 2000;83(3):287-93.
2000: Nick R Maisey; ME Hill; A Webb; David Cunningham; Glenn D Flux; AR Padhani; Robert J Ott; Andy Norman; L Bishop
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
European journal of cancer (Oxford, England : 1990) 2000;36(2):200-6.
1999: RA Popescu; AC Wotherspoon; David Cunningham; Andy Norman; JA Prendiville; ME Hill
Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experience.
European journal of cancer (Oxford, England : 1990) 1999;35(6):928-34.
1999: Justin S Waters; Andy Norman; David Cunningham; John Howard Scarffe; Andrew Webb; P Harper; Johnathan Keith Joffe; M Mackean; J Mansi; M Leahy; A Hill; Jacqui Oates; Sheela Rao; Marianne Nicolson; Tamas Hickish
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.
British journal of cancer 1999;80(1-2):269-72.
1999: Laura Assersohn; Andy Norman; David Cunningham; T Benepal; P J Ross; Jacqui Oates
Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma.
British journal of cancer 1999;79(11-12):1800-5.
1998: C Crawley; P Ross; Andy Norman; A Hill; David Cunningham
The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
British journal of cancer 1998;78(4):508-10.
1998: Tamas Hickish; Ian E Smith; Marianne Nicolson; Sue Ashley; Kathy Priest; L Spencer; Andy Norman; Gary Middleton; M E R O'Brien
A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
British journal of cancer 1998;77(11):1966-70.
1997: Paul Ross; Andy Norman; David Cunningham; Andrew Webb; Tim Iveson; AR Padhani; JA Prendiville; M Watson; Alison Massey; RA Popescu; Jacqui Oates
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):995-1001.
1997: Andrew Webb; David Cunningham; John Howard Scarffe; P Harper; Andy Norman; Johnathan Keith Joffe; M Hughes; J Mansi; Michael Findlay; A Hill; Jacqui Oates; Marianne Nicolson; Tamas Hickish; M O'Brien; Tim Iveson; M Watson; Craig Underhill; Andrew M Wardley; M Meehan
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):261-7.
1996: Andrew Webb; P Scott-Mackie; David Cunningham; Andy Norman; J Andreyev; M O'Brien; J Bensted
The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(1):63-8.
1995: Marianne Nicolson; Andrew Webb; David Cunningham; Andy Norman; M O'Brien; A Hill; Tamas Hickish
Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(8):801-4.
1995: M Hill; Andy Norman; David Cunningham; Michael Findlay; M Watson; V Nicolson; Andrew Webb; Gary Middleton; F Ahmed; Tamas Hickish
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2317-23.
1995: P A Ellis; Andy Norman; A Hill; M E O'Brien; Marianne Nicolson; Tamas Hickish; David Cunningham
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1594-8.
1995: Andrew Webb; P Scott-Mackie; David Cunningham; Andy Norman; J Andreyev; M O'Brien; J Bensted
The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):581-7.
1995: M Hill; Andy Norman; David Cunningham; Michael Findlay; V Nicolson; A Hill; A Iveson; C Evans; Johnathan Keith Joffe; Marianne Nicolson
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1297-302.
1995: A Bamias; David Cunningham; V Nicolson; Andy Norman; M Hill; Marianne Nicolson; M O'Brien; Andrew Webb; A Hill
Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.
British journal of cancer 1995;71(3):583-6.
1994: Michael Findlay; David Cunningham; Andy Norman; J Mansi; Marianne Nicolson; Tamas Hickish; V Nicolson; A Nash; N Sacks; H Ford
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(7):609-16.
1994: Michael Findlay; A Hill; David Cunningham; Andy Norman; Marianne Nicolson; H Ford; J Husband; C Evans; R Carter
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):239-43.